language_icon
EN
HI

Gennex Laboratories Share price

GENNEX

10.36

0.08 (0.78%)
Last updated on 24 Apr, 2026 | 15:59 IST
Today's High

10.48

Today's Low

10.15

52 Week Low

7.05

52 Week High

17.25

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Gennex Laboratories Chart

Gennex Laboratories Share Key Metrics

Volume
1.80 L
Market Cap
251.69 CR
LTQ@LTP
1@10.36
ATP
10.35
Var Margin
26.72 %
Circuit Range
8.23-12.33
Delivery %
76.38 %
Value
18.64 L
ASM/GSM
No
Market Lot
1

Summary

Gennex Laboratories share price stands at ₹10.36 at 24 Apr, 2026 | 15:59. The stock Gennex Laboratories intraday movement has stayed between ₹10.15 and ₹10.48, while on a 52-week basis it has fluctuated from ₹7.05 to ₹17.25.
In terms of trading activity, Gennex Laboratories has recorded a volume of 180105 shares. The Gennex Laboratories has a market cap of ₹242947674. The stock’s Average Traded Price (ATP) stands at ₹1035, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 1036.
The Gennex Laboratories operates within a circuit range of ₹8.23-12.33 – ₹8.23-12.33, with a Value of ₹18.64 L. The Delivery Percentage for the day is 76.38%. Additionally, Gennex Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Gennex Laboratories Fundamentals

View More
P/E Ratio

14.3

P/B Ratio

1.15

Div. Yield

0

Sector P/E

63.82

Sector P/B

3.5

Sec. Div. Yield

0.57

Gennex Laboratories Resistance and Support

Pivot 10.36

Resistance

First Resistance

10.51

Second Resistance

10.74

Third Resistance

10.89

Support

First Support

10.13

Second Support

9.98

Third Support

9.75

Gennex Laboratories Shareholding Pattern

View More
  • 2016-17
  • 2022-23
  • 2024-25
  • 2025-26
  • 2026-27
  • 2023-24
  • 2021-22
  • 2020-21
  • 2019-20
  • 2018-19
Total Promoters
Segment
Percent

Total Promoters

18.42%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

81.58%

Others

0%

Total Promoters
MAR '24
18.42%
JUN '24
18.42%
SEP '24
18.42%
DEC '24
18.42%

Gennex Laboratories Corporate Actions

DateAgenda
2026-04-16Others
2026-02-14Quarterly Results
2025-11-14Quarterly Results
2025-09-04A.G.M.
2025-08-14Quarterly Results
2025-05-30Audited Results
2025-02-14Quarterly Results

Gennex Laboratories News

Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Revised Outcome

Gennex Laboratories board approved convening an EGM on May 12, 2026, to regularize Additional Director Ms. Khushbu Kachhawa. NSDL has been appointed to facilitate e-voting for the EGM.
Apr 17 2026 18:04:00

Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for For Meeting Held On April 16, 2026 Of Gennex Laboratories Limited To Conduct EGM

Gennex Laboratories board approved calling an EGM on May 12, 2026, to regularize additional director Ms. Khushbu Kachhawa. NSDL will facilitate e-voting for the meeting, scheduled from May 09-11, 2026.
Apr 16 2026 17:04:00

Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Meeting To Be Held On Thursday, April 16, 2026

Gennex Laboratories will convene a Board Meeting on April 16, 2026, to discuss holding an Extraordinary General Meeting (EGM). The EGM's primary agenda is to regularize the appointment of Additional Director Ms. Khushbu Kachhawa.
Apr 08 2026 15:04:00
Read More

About Gennex Laboratories

NSE : 0  
BSE : 531739  
ISIN : INE509C01026  

PRUDENTIAL PHARMACEUTICALS LIMITED was originally incorporated under the name of Pharmasia Drugs and Chemicals Private Limited on 25th June 1985 in the state of Karnataka. The Company was subsequently shifted to Andhra Pradesh with effect from 29th March 1990. The Company has been promoted by Pharmasia Limited a Company registered under the Companies Act 1956 and having its registered office at 49 BHEL Enclave Akbar Road Secunderabad - 500 003. The Company had acquired a sick bulk drug manufacturing unit of SPS Chemicals Private Limited a sick unit assisted by the Andhra Pradesh State Financial Corporation Limited located at 133 Bollaram Medak Dist. in an auction in January 1993 by paying a lumpsum consideration of Rs.13.25 lacs and undertaking to pay off the term loan overdues amounting to Rs.24 lacs to APSFC which has since been paid off.The Company became a Deemed Public Limited Company with effect from 6th February 1993 as per the provisions of section 43A(1) of the Companies Act 1956. The Company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November 1994. A fresh certificate of incorporation consequent upon the conversion of the Company was issued by the Registrar of Companies Andhra Pradesh on 15th February 1995. The Company''s name was subsequently changed to Prudential Pharmaceuticals Limited and a fresh certificate of incorporation consequent upon change of name of the Company was issued by the Registrar of Companies Andhra Pradesh on 22nd February 1995.Mr.Vinod Baid & his associates acquired the entire holding of Pharmasia Limited amounting to 140018 shares at their face value (the consideration for which has been paid in cash) in November 1994 with a view to implement the project to set up facilities for manufacturing bulk drugs.The controlling interest held by the erstwhile promoter group was acquired by Mr.Vinod Baid & Associates by transfer of shares by following the procedure set out in the Companies Act 1956 and the rules framed there under i.e. by executing transfer deeds in prescribed form in favour of the transferees.At the time of take-over the Company had certain plant and machinery which has been detailed elsewhere in the prospectus and had also placed orders for certain other plant and machinery. After the takeover the company under the new management had taken up the implementation of the project in right earnest. The products were identified additional equipment required (other than those already available and those ordered) were acquired and the manpower required for manning the project were hired. The trial production was completed in September 1995 and the Commercial Production has already commenced.The Details of the position of the Company as at 31st March 1994 the cut-off date considered by Mr. Vinod Baid & Associates for the purpose of acquisition of controlling interest in the Company has been given as under:

Read More

Gennex Laboratories Management

NamePosition
Dinesh Kumar KejriwalCompany Secretary & Compliance Officer
Arihant BaidManaging Director
View More

Gennex Laboratories FAQs

The Buying Price of Gennex Laboratories share is 10.36 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Gennex Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gennex Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Gennex Laboratories shares is 14.3. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Gennex Laboratories shares is 1.15. Useful to assess the stock's value relative to its book value.

To assess Gennex Laboratories’s valuation compare Sector P/E, P/B which are 63.82 & 3.5 with sector averages, along with growth rates and financial metrics.

The Market Cap of Gennex Laboratories is 251.69 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Gennex Laboratories share price is 17.25 & 7.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Gennex Laboratories belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost